The global digital PCR market size was valued at USD at 2.25 billion in the year 2018 and is anticipated to witness CAGR of 8.5% during forecast period 2021-2028.
Global Digital PCR Market Overview:
Digital PCR is the quantitative PCR method that measures the amount of DNA or RNA present in given sample. The benefit of using digital PCR is it has high tolerance to inhibitors. It can also distinguish expression of alleles and measure determines the cancer genes. Different applications of digital PCR are paternity testing, recognition f hereditary illness, DNA cloning and forensic science. This market report thorough and specialized study gives more focus on the worldwide medical device market trend analysis. Further this report depicts an overview of digital PCR market by doing detailed market categorization by application, technology, component, geography and end user. The global digital PCR market is projected to record high growth according to forecast period. It further describes a few key statistics on the market status of the prominent industry players of digital PCR market and covers opportunities in the market. This market report gives details about factors that are effectively affecting digital PCR Market from supply as well as demand side. It even does the analysis of market dynamics such as future trend, drivers, restraints and opportunities according to the forecast period. It also covers economic, technological, social and political factors affecting the market in the regions. It gives complete PEST analysis for the regions such as MEA, North America, Europe, APAC and Central America.
There are some prominent factors that drive the market growth is increase in technological advancement, infectious disease and aged population. Genome based drug detection and increase in penetration of digital PCR in several developing countries are anticipated to bring best opportunities for industries to grow in the market. Even the accomplishment of Human Genomic Project is another chief factor to drive the digital PCR market growth.
The global digital PCR market is classified according to component, end users, application and technology. On the basis of technology, the market is classified as Beaming digital PCR and droplet digital PCR. According to component, the market is classified into reagents, instruments, software & services and consumables. Based on application, the market is categorized into forensic, clinical and research. The market is segmented into forensic laboratories, diagnostic centers, pharmaceutical and biotech companies, hospitals, organization, and clinical research. This market report gives thorough outline of the industry that includes qualitative and quantitative data. It gives in-detail summary and forecasts about the global digital PCR market on the basis of different sectors. It also depicts market size and forecast evaluations from 2017 to 2027 along with covering five prominent regions including South & Central America, North America, Europe, Middle East and Africa and Asia Pacific. The market analysis also tells us about forecast of 18 countries worldwide along with present trend and opportunities prevailing in the region. The market is also sub-categorized by each region and by particular countries and sections.
Key Market Players
Both the organic and inorganic growth strategies are covered as key advancements in the digital PCR market. There are a number of industries giving focus on organic growth developments like product approvals, product launches and others like patents and events. Collaborations, acquisitions and partnership are the inorganic growth strategies covered in the report. Such activities allow market players to expand their business and customer base. This market report contains the profiles of the key players along with their SWOT analysis. Moreover, it further focuses on key players along with their company profiles, financial information and services offered. Below is given the list of leading market players operating in the digital PCR market:
- Takara bio, Inc.
- F. Hoffmann-la Roche ltd.
- Agilent technologies, Inc.
- Promega corporation
- Abbott laboratories
- Biomerieux SA
- Merck KGaA